[Chinese guidelines for the diagnosis and treatment of allergic asthma (2019, the first edition)].

Allergic asthma is an important phenotype of asthma, accounting for sixty to eighty percent of the whole asthma population. This guideline was divided into 15 chapters, which provided a detailed introduction to epidemiology, pathogenesis, common allergens, clinical manifestation and the principles of diagnosis, treatment and prevention of allergic asthma, and highlighted the similarities and differences of allergic and non-allergic asthma. According to the principles of international and national asthma guidelines, this guideline placed special emphasis on allergen specific immunotherapy, anti-IgE therapy, anti-allergy therapy, management of allergic comorbidities and tertiary prevention. Based on the evidence-based medicine and clinical practice in China, the guideline made recommendations to guide the diagnosis, treatment and management of allergic asthma in China.过敏性哮喘是支气管哮喘中的重要类型，占支气管哮喘的60%~80%。本指南分为十五个章节，从过敏性哮喘的流行病学、发病机制、常见过敏原、临床表现到诊断、治疗和预防原则进行了详细的介绍，突出了过敏性哮喘与非过敏性哮喘的异同，在国际和我国支气管哮喘指南基本原则的基础上，重点介绍了特异性免疫治疗、抗IgE治疗、抗过敏治疗、合并其他过敏性疾病的治疗及三级预防措施，根据循证医学证据和我国临床实践，提出了推荐意见，以指导我国过敏性哮喘的诊治与管理。.